Funding of $36.5 million granted to IXI for the creation of autofocus glasses technology
In a groundbreaking development for the eyewear industry, IXI, a startup specialising in wearable technology, optics, and industrial design, has launched the world's first autofocus glasses. These innovative glasses use real-time, ultra-low-power eye tracking technology to automatically adjust focus, addressing common frustrations with traditional progressive lenses and improving vision for the visually impaired[1][3][5].
Founded in 2021, IXI has disrupted the $200 billion eyewear market with dynamic lenses that automatically adapt to the wearer's eyes[2]. The company emerged from stealth in April 2025, having secured $36.5 million in Series A funding, reflecting strong investor confidence in their technology[4].
The funding round was led by Plural, with participation from Tesi, byFounders, Heartcore, Eurazeo, FOV Ventures, Tiny Supercomputer, and IXI's existing investors[2]. Sten Tamkivi, Partner at Plural, stated that IXI's team's expertise puts them at the forefront of advanced optics and eye-tracking developments[6].
IXI's autofocus glasses represent a potential transformation of the spectacles market, aiming to enhance visual clarity dynamically, which is a notable advancement in both wearable technology and optical health solutions[1][3]. The glasses are designed to provide a wider field of view and work as nature intended eyes to work[7].
The new funding will be used to complete the product development of IXI Adaptive Eyewear and kick off commercial operations. The company's technology may also play a key role in facilitating mainstream adoption of AI-powered smart glasses by overcoming usability and desirability barriers in collaboration with major eyewear industry players[3][5].
Meanwhile, other developments in the medical field include advancements by Aptamer Group and Neuro-Bio in a new Alzheimer's diagnostic test[8], and Ceryx Medical securing $15 million to advance its groundbreaking heart failure technology[9]. These developments were also reported in "Medical Device Manufacturing News".
Interestingly, the founders of IXI, Niko Eiden (CEO) and Ville Miettinen (Chief Algorithm Officer), previously co-founded the premium mixed reality hardware startup, Varjo[10]. With their combined expertise, IXI is creating a new category of eyewear, featuring unique real-time and ultra-low-power eye tracking and state-of-the-art dynamic lens technology.
This news marks an exciting time for the eyewear and medical technology industries, as innovations continue to push the boundaries of what is possible.
[1] Waseda University's Breakthrough in Eye Wear with Advanced Contact Lenses [2] IXI Raises $36.5 Million in Series A Funding [3] IXI Disrupts the Eyewear Market with Autofocus Glasses [4] IXI Unveils Autofocus Glasses, Raising $36.5 Million in Series A Funding [5] IXI's Autofocus Glasses: A Game Changer in the Eyewear Industry [6] Plural Leads Series A Funding Round for IXI [7] IXI's Autofocus Glasses: A Revolution in Spectacles Market [8] Aptamer Group and Neuro-Bio's Advancements in Alzheimer's Diagnostic Test [9] Ceryx Medical Secures $15 Million for Heart Failure Technology [10] The Founders of IXI: From Varjo to Autofocus Glasses
Gadget enthusiasts may anticipate wearing technology-infused eyewear as IXI, a startup specializing in wearable tech, optics, and industrial design, develops innovative autofocus glasses with real-time, ultra-low-power eye tracking technology. As these gadgets set to challenge traditional progressive lenses and improve vision for the visually impaired, they also represent a potential transformation in the spectacles market and advancements in both wearable technology and optical health solutions.
